The Challenge
A leading pharmaceutical company was developing a highly moisture-sensitive powder formulation. Initially, they considered using glass bottles due to their excellent moisture barrier properties. However, this approach presented several challenges:
- Increased regulatory and operational risk
- Limited availability of Pharmaceutical packing contractors willing to handle glass
- Higher transportation costs due to glass weight
- Incompatibility with the company’s sustainability strategy
The Solution
LOG Pharma proposed using its advanced MONOBLOCK HDPE bottles — engineered with enhanced barrier properties.
These bottles demonstrated a moisture vapor transmission rate (MVTR) 4 times lower than standard HDPE bottles, offering a viable alternative to glass without compromising on performance or sustainability.
To meet the customer’s specific fill line and product requirements, a customized bottle size was developed.
The Process
Initial development faced challenges: the first-generation MONOBLOCK did not fully meet the customer’s moisture barrier specifications, and early stability tests fell short of target results.
Our R&D team intervened and further optimized the MONOBLOCK barrier formulation. Following these improvements, the updated bottles successfully passed the customer’s rigorous stability testing.
The Result
The pharmaceutical company adopted the MONOBLOCK solution as the primary packaging for the product, enabling:
- Elimination of glass from the packaging system
- Compliance with moisture sensitivity specifications
- Improved compatibility with pharmaceutical packaging lines
- Alignment with sustainability objectives